The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world effectiveness of lenvatinib monotherapy among unresectable hepatocellular carcinoma patients treated in United States clinical practices.
 
Amit G. Singal
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Eisai; Exact Sciences; Exelixis; Genentech; Glycotest; Roche; Target Pharmasolutions; Wako Diagnostics
Research Funding - Abbvie (Inst); Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Eisai; Exelixis
 
Saurabh P Nagar
Research Funding - RTI Health Solutions (Inst)
 
Abigail Hitchens
No Relationships to Disclose
 
Shrividya Iyer
Employment - Eisai; Pfizer
Stock and Other Ownership Interests - Pfizer
Research Funding - Eisai; Pfizer
Travel, Accommodations, Expenses - Eisai; Pfizer